A new study has found another benefit of GLP-1 drugs, including Ozempic and Wegovy. In addition to helping with weight loss, they lower the risk of Alzheimer’s disease and dementia for Type 2 diabetics. Health reporter Katherine Ward has the details.
Health
GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes
More Videos
-
Canada on the verge of losing measles elimination status
-
Health Matters: Measles cases have potential to surge in Western Canada
-
1,800+ measles cases confirmed across Canada since Oct. 2024
-
Health Matters: Ontario health minister defends measles approach as case counts continue to rise
-
Is Canola oil good for you? Dietician dispels misconceptions around seed oils
-
Health Matters: Coconut meat recalled due to Salmonella
You are viewing an .
View Original Article